Clearmind Medicine Inc.

EDGAR

217 filing records in this dataset, filed from 2022-06-29 to 2026-10-08. Reported financial figures are available; chart coverage varies by period.

Watchlist
Cash and cash equivalents
9.26 million USD Source
Exact value

9257766 USD

Long-term debt including current maturities
Not available
Shares outstanding
Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Operating cash flow

-6.22 million USD

2025-05-01 – 2026-04-30

Exact inputs and evidence
  • Operating cash flow: -3448671 USD · 2024-11-01 – 2025-07-31 Source
  • Operating cash flow: -2363833 USD · 2024-11-01 – 2025-04-30 Source
  • Operating cash flow: -4734498 USD · 2024-11-01 – 2025-10-31 Source
  • Operating cash flow: -3448671 USD · 2024-11-01 – 2025-07-31 Source
  • Operating cash flow: -2084949 USD · 2025-11-01 – 2026-01-31 Source
  • Operating cash flow: -3853029 USD · 2025-11-01 – 2026-04-30 Source
  • Operating cash flow: -2084949 USD · 2025-11-01 – 2026-01-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-08.

Financial data available through: 2025-10-31.

Coverage by financial measure
  • revenue: No compatible figures in this window
  • Operating income: 3 of 11 periods available· newest 2022-10-31
  • net income: No compatible figures in this window
  • Operating cash flow: 5 of 11 periods available· newest 2025-10-31
  • Capital expenditure: Multiple units; comparison withheld· newest 2022-10-31
  • Total assets: Multiple units; comparison withheld· newest 2025-10-31
  • Total liabilities: Multiple units; comparison withheld· newest 2025-10-31
  • Current assets: Multiple units; comparison withheld· newest 2025-10-31
  • Current liabilities: Multiple units; comparison withheld· newest 2025-10-31
  • Cash and cash equivalents: Multiple units; comparison withheld· newest 2025-10-31
  • long term debt: No compatible figures in this window
  • shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Operating cash flow

    +USD 124,161

    Prior period

    −USD 4.86 million

    –

    Current period

    −USD 4.73 million

    –

    Exact inputs and evidence

    -4734498 − -4858659 = 124161 USD

    -4858659 USD · 2023-11-01 – 2024-10-31

    Inspect prior input Prior source

    -4734498 USD · 2024-11-01 – 2025-10-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Net income, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.
Values and sources
Revenue values and source evidence
PeriodSeriesValueSource evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValueSource evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2021 2020-11-01 – 2021-10-31
Unavailable Not reported for this period.
−USD 2.08 million
Exact value

Exact value: -2077096 USD

2020-11-01 – 2021-10-31: -2077096 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2022 2021-11-01 – 2022-10-31
Unavailable Not reported for this period.
−USD 3.72 million
Exact value

Exact value: -3724494 USD

2021-11-01 – 2022-10-31: -3724494 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2023 2022-11-01 – 2023-10-31
Unavailable Not reported for this period.
−USD 6.3 million
Exact value

Exact value: -6301472 USD

2022-11-01 – 2023-10-31: -6301472 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2024 2023-11-01 – 2024-10-31
Unavailable Not reported for this period.
−USD 4.86 million
Exact value

Exact value: -4858659 USD

2023-11-01 – 2024-10-31: -4858659 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2025 2024-11-01 – 2025-10-31
Unavailable Not reported for this period.
−USD 4.73 million
Exact value

Exact value: -4734498 USD

2024-11-01 – 2025-10-31: -4734498 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

217 filings · 882 latest values · 882 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001892500, 1892500, CMND, edgar:1892500

Also known as Clearmind Medicine Inc.